UY30157A1 - USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES AS NEUROPROTECTING AGENTS - Google Patents

USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES AS NEUROPROTECTING AGENTS

Info

Publication number
UY30157A1
UY30157A1 UY30157A UY30157A UY30157A1 UY 30157 A1 UY30157 A1 UY 30157A1 UY 30157 A UY30157 A UY 30157A UY 30157 A UY30157 A UY 30157A UY 30157 A1 UY30157 A1 UY 30157A1
Authority
UY
Uruguay
Prior art keywords
benzo
derivatives
sulfamida
heteroaril
treat
Prior art date
Application number
UY30157A
Other languages
Spanish (es)
Inventor
Virginia L Smith-Swintosky
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY30157A1 publication Critical patent/UY30157A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención consiste en métodos para la neuroproteción, para tratar un trastorno neurodegenerativo agudo, para tratar un trastorno neurodegenerativo crónico y/o para prevenir la muerte o dano neuronal que sigue a un trauma o lesión del cerebro, cabeza y/o médula espinal, que comprende administrar a un sujeto que lo necesite una cantidad terapéuticamente efectiva de uno o más derivados nuevos de benzo-heteroaril sulfamida de fórmula (I) de acuerdo con lo definido en la presente.The present invention consists of methods for neuroprotection, to treat an acute neurodegenerative disorder, to treat a chronic neurodegenerative disorder and / or to prevent death or neuronal damage that follows trauma or injury to the brain, head and / or spinal cord, which comprises administering to a subject in need thereof a therapeutically effective amount of one or more new benzo-heteroaryl sulfamide derivatives of formula (I) as defined herein.

UY30157A 2006-02-15 2007-02-14 USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES AS NEUROPROTECTING AGENTS UY30157A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77372506P 2006-02-15 2006-02-15

Publications (1)

Publication Number Publication Date
UY30157A1 true UY30157A1 (en) 2007-07-31

Family

ID=38813276

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30157A UY30157A1 (en) 2006-02-15 2007-02-14 USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES AS NEUROPROTECTING AGENTS

Country Status (4)

Country Link
AR (1) AR059500A1 (en)
PE (1) PE20070980A1 (en)
TW (1) TW200808298A (en)
UY (1) UY30157A1 (en)

Also Published As

Publication number Publication date
PE20070980A1 (en) 2007-09-24
AR059500A1 (en) 2008-04-09
TW200808298A (en) 2008-02-16

Similar Documents

Publication Publication Date Title
CL2019001079A1 (en) Methods for using indazole-3-carboxamides and their use as inhibitors of the wnt / b-catenin signaling pathway.
CY1112444T1 (en) USE OF SULFAMIDI PRODUCERS OF BENZO-SYNTHESIZED HYDROCYCLE AS NEURO-PROTECTIVE AGENTS
BR112015020466A2 (en) cdc7 inhibitors
EP4272757A3 (en) Modified nk-92 cells for treating cancer
CL2008001374A1 (en) Compounds derived from pyrazolo pyrimidines, inhibitors of pde9; pharmaceutical composition comprising said compounds; Useful in the treatment of a neurodegenerative and cognitive disorder such as Alzheimer's disease and schizophrenia.
UY35391A (en) 2-AZA-BICYCLE ACID [2.2.1] HEPTANO-3-CARBOXILICO (BENCIL-CYANOMETIL) -CATPSIN C INHIBITING REPLACED MEASURES
MX2009013332A (en) Ire-1a inhibitors.
BR112015026006A2 (en) methods for treating cancer with the use of tor kinase inhibitor combination therapy
MX2014014831A (en) Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer.
MX362442B (en) Ire-1-alpha inhibitors.
EA201200355A1 (en) METHODS OF PREVENTION AND TREATMENT OF ISCHEMIA OF THE BRAIN
CR20120202A (en) METHODS AND COMPOSITIONS TO TREAT CANCER
BR112013008140A8 (en) "IMIDAZOTRIAZINONE COMPOUNDS".
CL2015001279A1 (en) Compounds derived from pyridine, urate transporter inhibitors urat 1; pharmaceutical composition that includes them; use for the treatment or prevention of diseases such as gout, hyperuricemia, hypertension, kidney diseases, among others.
CL2014000246A1 (en) Phenyl-3-aza-bicyclo [3.1.0] hex-3-yl-methanone derivative compounds, glycine transporter inhibitors (glyt1); pharmaceutical composition that contains them; pharmaceutical combination; and its use in the treatment of Alzheimer's disease, cognitive disorders in schizophrenia, psychosis, psychiatric disorders, among others
ES2689971T3 (en) Use of PDE7 inhibitors for the treatment of movement disorders
BR112017003433A2 (en) cathepsin c spirocyclic inhibitors
BRPI0908635B8 (en) compound and/or a pharmaceutically acceptable salt thereof and pharmaceutical composition
IL288195A (en) Use of cannabidiol in the treatment of epileptic spasms
AR067395A1 (en) INHIBITION OF HTRA1 MEDIATED BY IARN FOR THE TREATMENT OF MACULAR DEGENERATION
WO2007095613A3 (en) Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
AR094318A1 (en) PHARMACEUTICAL COMPOUND FOR THE PREVENTION AND TREATMENT OF A COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISORDER OR DISEASE
BRPI0821114A2 (en) Compound, use of a compound and method to treat any cancer-affected mammal
UY30157A1 (en) USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES AS NEUROPROTECTING AGENTS
BR112016029624A2 (en) therapy using a factor xii inhibitor in a neurotraumatic disorder